2023
DOI: 10.21873/anticanres.16449
|View full text |Cite
|
Sign up to set email alerts
|

Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles